ArticleNaunyn-Schmiedeberg's archives of pharmacology2025
Citronellol protects renal function by exerting anti-inflammatory and antiapoptotic effects against acute kidney injury induced by folic acid in mice.
Article in Naunyn-Schmiedeberg's archives of pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- The protective role of nicardipine in dextran sulfate sodium-induced colitis in mice: Modulating inflammation and apoptosis.Toxicology reports · 2025Article
- Citronellol Reduces Sepsis-Induced Renal Inflammation via AP-1/NF-κB/TNF-α Pathway.Biomolecules · 2025Article
- Nephroprotective Effect ofInternational journal of molecular sciences · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acute kidney injury (AKI) is characterized by an abrupt cessation of kidney function. Folic acid-induced renal tubular damage is marked by immense inflammation and apoptosis in the kidney. Citronellol is a type of natural monoterpene alcohol commonly used in traditional medicine. Citronellol possesses pharmacological properties such as antioxidants, anti-inflammatory, and analgesic effects. This study aimed to investigate the reno-protective effect of citronellol against folic acid-induced AKI in mice models. Mice were divided into four groups. In addition to control and AKI-induction groups, two treatment groups were mice that received 50 or 100 mg/kg/day of citronellol orally for four consecutive days. On day 4, mice also received a single injection of folic acid (250 mg/kg) and were euthanized after 48 h. Citronellol 50 and 100 mg/kg rescued renal function as indicated by the significant reduction of serum urea, serum creatinine, and gene expression of KIM-1 compared to the non-treated group. In addition, citronellol 50 and 100 mg/kg relieved renal inflammation by significantly downregulating NF-κB, IL-6, and IL-1β gene expressions compared to the non-treated mice. Furthermore, citronellol retarded renal apoptotic events by the significant decline in renal tissue BAX and cleaved caspase-3 levels compared to non-treated mice. Histopathological report of renal tissue provides further evidence that augments the above results. The study highlighted the importance of some natural compounds that could have a place in therapeutic procedures for kidney injury, as observed by the strong renal protective effects of citronellol against AKI and remarkable anti-inflammatory and antiapoptotic actions.
Indexed as
Identifiers
39621091What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.